Abpro Bio Co., Ltd. (KOSDAQ:195990)

Abpro Bio Revenue

Abpro Bio had revenue of 7.89B KRW in the quarter ending March 31, 2026, a decrease of -11.11%. This brings the company's revenue in the last twelve months to 30.94B, down -10.14% year-over-year. In the year 2025, Abpro Bio had annual revenue of 31.92B with 0.82% growth.

• Revenue (ttm): 30.94B
• Revenue Growth: -10.14%
• P/S Ratio: 1.02
• Revenue / Employee: 703.11M
• Employees: 44
• Market Cap: 31.66B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	31.92B	259.71M	0.82%
Dec 31, 2024	31.66B	6.29B	24.78%
Dec 31, 2023	25.38B	3.26B	14.76%
Dec 31, 2022	22.11B	-10.80B	-32.82%
Dec 31, 2021	32.91B	-2.88B	-8.05%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 3, 2026

Data Sources Report a data error